ConductScience.org, home

Trial · NCT07885020

NEURO-IS: Neurophysiology of Inner Speech Across Neurotypical Participants.

NCT07885020, Not applicable, Recruiting, University of Liege

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. NEURO-IS: Neurophysiology of Inner Speech Across Neurotypical Participants. Trials, record NCT07885020. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885020

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
NEURO-IS: Neurophysiology of Inner Speech Across Neurotypical Participants.
NCT number
NCT07885020
Status
Recruiting
Phases
Not applicable
Enrollment
35 participants, estimated
Lead sponsor
University of Liege
Conditions
Healthy Volunteer
Interventions
Inner Experience Induction Tasks and hdEEG
First posted
2026-10-21
Last updated
2026-10-26

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryModulation of EEG spectral power (Alpha, Beta, and Gamma bands)Day 1
The primary evaluation relies on the analysis of high-density EEG signals in response to the induction of inner experiences. Specifically, the analysis will focus on identifying the most robust paradigms by examining specific EEG characteristics: modulation in the beta and gamma frequency bands for Inner Speech (IS), and alpha band desynchronization for Visual Mental Imagery (VMI). The goal is to identify the most appropriate and effective tasks to generate these detectable biomarkers.
SecondaryDifference in EEG biomarkers between passive listening and active mental repetitionDay 1
Investigating the neurophysiological correlates of the passive listening of words in comparison with their silent repetition (Inner Speech). This involves a comparative analysis of EEG biomarkers between these different tasks to determine the specific electrophysiological signatures of active mental generation versus passive semantic processing.
SecondaryCorrelation between self-consciousness scores and phenomenological dimensions of inner speechDay 1
To better understand the links between self-consciousness and the phenomenological components of inner speech. Self-consciousness will be evaluated using the Short French Meta-Cognitions Questionnaire (MCQ-30) and the Rumination-Reflection Questionnaire (RRQ). These scores will be correlated with the detailed profile of inner experiences obtained through the Varieties of Inner Speech Questionnaire-Revised (VISQ-R) and the Vividness of Visual Imagery Questionnaire (VVIQ). A specific aim is to evaluate whether increased reflective consciousness is positively correlated with the dialogic and evaluative/critical dimensions of inner speech.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers26

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
10074710BACKGROUNDPubMed
10725191BACKGROUNDPubMed
11287137BACKGROUNDPubMed
12811732BACKGROUNDPubMed
16260154BACKGROUNDPubMed
16971533BACKGROUNDPubMed
18258456BACKGROUNDPubMed
20003916BACKGROUNDPubMed
23049515BACKGROUNDPubMed
23971982BACKGROUNDPubMed

1 to 10 of 26

See all 26 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07885020

GET https://conductscience.org/api/trials/v1/NCT07885020/papers?page=2